{"meta":{"version":1,"warehouse":"4.0.2"},"models":{"Asset":[{"_id":"themes/auto/source/css/style.styl","path":"css/style.styl","modified":0,"renderable":1},{"_id":"themes/auto/source/fancybox/jquery.fancybox.min.css","path":"fancybox/jquery.fancybox.min.css","modified":0,"renderable":1},{"_id":"themes/auto/source/js/jquery-3.4.1.min.js","path":"js/jquery-3.4.1.min.js","modified":0,"renderable":1},{"_id":"themes/auto/source/js/script.js","path":"js/script.js","modified":0,"renderable":1},{"_id":"themes/auto/source/fancybox/jquery.fancybox.min.js","path":"fancybox/jquery.fancybox.min.js","modified":0,"renderable":1},{"_id":"themes/auto/source/css/fonts/fontawesome-webfont.eot","path":"css/fonts/fontawesome-webfont.eot","modified":0,"renderable":1},{"_id":"themes/auto/source/css/fonts/fontawesome-webfont.svg","path":"css/fonts/fontawesome-webfont.svg","modified":0,"renderable":1},{"_id":"themes/auto/source/css/fonts/FontAwesome.otf","path":"css/fonts/FontAwesome.otf","modified":0,"renderable":1},{"_id":"themes/auto/source/css/fonts/fontawesome-webfont.ttf","path":"css/fonts/fontawesome-webfont.ttf","modified":0,"renderable":1},{"_id":"themes/auto/source/css/fonts/fontawesome-webfont.woff","path":"css/fonts/fontawesome-webfont.woff","modified":0,"renderable":1},{"_id":"themes/auto/source/css/fonts/fontawesome-webfont.woff2","path":"css/fonts/fontawesome-webfont.woff2","modified":0,"renderable":1},{"_id":"themes/auto/source/css/images/banner.jpg","path":"css/images/banner.jpg","modified":0,"renderable":1}],"Cache":[{"_id":"source/tags/index.md","hash":"7677818036b20939d1cf16e4b646b8209e98d236","modified":1662695239335},{"_id":"source/categories/index.md","hash":"49f756bed5dc4b6301d27f29149c1e946074f653","modified":1662695238051},{"_id":"source/_posts/What-kind-of-diseases-or-conditions-can-be-diagnosed-through-in-vitro-tests.md","hash":"67bc86ec8c4fd8790fc783f7f1c97b1e55607a7a","modified":1662695251791},{"_id":"themes/auto/LICENSE","hash":"6b9b2b765430aa128b6c3c1341307ce973cc1b4e","modified":1662110698307},{"_id":"themes/auto/README.md","hash":"efc7ab25b471e17c4b0b5aa94f84305a30cc337d","modified":1662110698308},{"_id":"themes/auto/custom.json","hash":"17720c32c5c823f442add2feae8aaccf85bcdef5","modified":1662370333568},{"_id":"themes/auto/_config.yml","hash":"584e0c8d81e13c8f5c5eaeced715ddc66e03aaf9","modified":1662695236711},{"_id":"themes/auto/languages/de.yml","hash":"d45cea36c5c83d7d09afcd1c26fff4a4c513c25b","modified":1662110698310},{"_id":"themes/auto/languages/en.yml","hash":"f26a34a7983d4bc17c65c7f0f14da598e62ce66d","modified":1662110698310},{"_id":"themes/auto/languages/fr.yml","hash":"8cb0fe4b6913b4d5b662cdd0108a923c90025f85","modified":1662110698312},{"_id":"themes/auto/languages/es.yml","hash":"e3b4937da4cd2d0393b8a0ba310e70fc605cc431","modified":1662110698311},{"_id":"themes/auto/languages/hu.yml","hash":"d22ec72d00567db3782661ab5ccdb2475469da4c","modified":1662110698312},{"_id":"themes/auto/languages/it.yml","hash":"7f09aa0520688e2de50cb5b6631998682f9200f5","modified":1662110698313},{"_id":"themes/auto/languages/ja.yml","hash":"3e2fedca096678c0c234ebffa4637828979296fa","modified":1662110698314},{"_id":"themes/auto/languages/ko.yml","hash":"11330316e3c1262474a2b496e40dbc29f93fe01b","modified":1662110698314},{"_id":"themes/auto/languages/mn.yml","hash":"088c2507d8f221416f99cf72d73641ba476a0f00","modified":1662110698315},{"_id":"themes/auto/languages/nl.yml","hash":"3d82ec703d0b3287739d7cb4750a715ae83bfcb3","modified":1662110698315},{"_id":"themes/auto/languages/ru.yml","hash":"2a476b4c6e04900914c81378941640ac5d58a1f0","modified":1662110698317},{"_id":"themes/auto/languages/no.yml","hash":"ddf2035e920a5ecb9076138c184257d9f51896a7","modified":1662110698316},{"_id":"themes/auto/languages/pt.yml","hash":"ae2c61b30e638f74f1a42c9ce39ac08d063b30f5","modified":1662110698316},{"_id":"themes/auto/languages/tr.yml","hash":"424f6e94ced575b51bb7dcebdc0f25d4f4c99fe2","modified":1662110698317},{"_id":"themes/auto/layout/.DS_Store","hash":"9b3d41e67c7dc45c122948d61996717b25e2808e","modified":1662110698320},{"_id":"themes/auto/languages/zh-CN.yml","hash":"15f3958fb3c81ad2be865f079cdade6d270073f0","modified":1662110698318},{"_id":"themes/auto/layout/archive.ejs","hash":"2703b07cc8ac64ae46d1d263f4653013c7e1666b","modified":1662110698334},{"_id":"themes/auto/layout/category.ejs","hash":"6bb634b555083f54904536b0f159c7b3e8febdd7","modified":1662110698335},{"_id":"themes/auto/layout/layout.ejs","hash":"f7570b1e861c455171a1d3da95beedb7c86cfb4c","modified":1662110698335},{"_id":"themes/auto/layout/page.ejs","hash":"7d80e4e36b14d30a7cd2ac1f61376d9ebf264e8b","modified":1662110698336},{"_id":"themes/auto/layout/index.ejs","hash":"aa1b4456907bdb43e629be3931547e2d29ac58c8","modified":1662110698335},{"_id":"themes/auto/layout/categories.ejs","hash":"6d88ac500be4872ca741a8b28757ad5c3ccb2b8c","modified":1662110698334},{"_id":"themes/auto/layout/tags.ejs","hash":"9d6c21cd9018a885b74e0b7a7bdd99dc0c2d4f46","modified":1662110698338},{"_id":"themes/auto/layout/post.ejs","hash":"7d80e4e36b14d30a7cd2ac1f61376d9ebf264e8b","modified":1662110698336},{"_id":"themes/auto/layout/tag.ejs","hash":"eaa7b4ccb2ca7befb90142e4e68995fb1ea68b2e","modified":1662110698337},{"_id":"themes/auto/layout/_partial/after-footer.ejs","hash":"a18092cc5a0c35808b0dd8b9565fc7f68dc10368","modified":1662110698321},{"_id":"themes/auto/layout/_partial/archive.ejs","hash":"86aad9773ccd7f797ca9ca06b2d6263e18bac0b1","modified":1662110698322},{"_id":"themes/auto/layout/_partial/archive-post.ejs","hash":"5062c723721d8497eebad372f57092ade45041f4","modified":1662110698321},{"_id":"themes/auto/layout/_partial/article.ejs","hash":"afdecdeb68b61bef3bcb4e4f5175d05e4b3160c5","modified":1662110698322},{"_id":"themes/auto/layout/_partial/footer.ejs","hash":"d63194190c7c0214ec632225c0dee7264191b9f0","modified":1662368613704},{"_id":"themes/auto/layout/_partial/head.ejs","hash":"37ef2abe1c2805b605c94437a1e83f4ac9011018","modified":1662110698324},{"_id":"themes/auto/layout/_partial/mobile-nav.ejs","hash":"347cf1befd2ea637c24bd5901929d8e36e359e75","modified":1662110698325},{"_id":"themes/auto/layout/_partial/header.ejs","hash":"9cd0895dd4968184199bc0519f074f43229f34ae","modified":1662110698324},{"_id":"themes/auto/layout/_partial/sidebar.ejs","hash":"055d489d60e264ebfd267f299ae1bf1a9bd19347","modified":1662368050538},{"_id":"themes/auto/layout/_widget/archive.ejs","hash":"3a6ad2700f4131982c2fa2fb3e0ec41d7514ce7f","modified":1662110698330},{"_id":"themes/auto/layout/_widget/recent_posts.ejs","hash":"98c85af1103af18b02c4f5f207fdfc48e207d794","modified":1662110698332},{"_id":"themes/auto/layout/_widget/tag.ejs","hash":"6017c54a8c3c8ff8db491cfbea3100c139da75d6","modified":1662110698332},{"_id":"themes/auto/layout/_widget/category.ejs","hash":"866790acc13fed44b7ef74c3e19c300a3d6180d8","modified":1662110698331},{"_id":"themes/auto/layout/_widget/tagcloud.ejs","hash":"7259c179aa0c41c02e467ad892292e90430aaabc","modified":1662110698333},{"_id":"themes/auto/source/css/_extend.styl","hash":"ad3d54845a5d199da9b4084d5388c47731dbebc3","modified":1662110698342},{"_id":"themes/auto/source/css/_variables.styl","hash":"56b7fad9b3acfd6f5bbc117c56e6f8a4f6e9073e","modified":1662110698350},{"_id":"themes/auto/source/css/style.styl","hash":"e9cb454199769b44f460d0b2f0ead19df75d6844","modified":1662110698374},{"_id":"themes/auto/source/fancybox/jquery.fancybox.min.css","hash":"1be9b79be02a1cfc5d96c4a5e0feb8f472babd95","modified":1662110698375},{"_id":"themes/auto/source/js/script.js","hash":"f2b703cb5e322281b6259a0e3b82b55f9af124ef","modified":1662110698378},{"_id":"themes/auto/layout/_partial/post/date.ejs","hash":"e78bda05fcf57b0e5e3a20cf3505d37fd69aaf46","modified":1662110698326},{"_id":"themes/auto/layout/_partial/post/category.ejs","hash":"16128d2422645e18d1b6882d4c4df17d895bd76e","modified":1662110698326},{"_id":"themes/auto/layout/_partial/post/tag.ejs","hash":"694b5101bcc44c9f9c1cc62e5ad2fdfb4b7c7a07","modified":1662110698328},{"_id":"themes/auto/layout/_partial/post/nav.ejs","hash":"cbb3819ce512bd24db8bad41b8617d46eba82fdc","modified":1662110698327},{"_id":"themes/auto/layout/_partial/post/gallery.ejs","hash":"b0bf3f5d923c261ca2b5fabab513f1ec2708c8ca","modified":1662110698327},{"_id":"themes/auto/layout/_partial/post/title.ejs","hash":"fd5d3187f4e3d45f8af08f93b263fca7ed666c75","modified":1662110698328},{"_id":"themes/auto/source/css/_partial/article.styl","hash":"52763559687b19734ea9640bc22f8f53e29ee06f","modified":1662110698343},{"_id":"themes/auto/source/css/_partial/header.styl","hash":"20f19a7876c2a54e07318418fc123a2880fc8fd6","modified":1662110698345},{"_id":"themes/auto/source/css/_partial/footer.styl","hash":"56f6ccaa1d5c5f48329f6051ab540a6dbcd7acc3","modified":1662110698344},{"_id":"themes/auto/source/css/_partial/comment.styl","hash":"2834870661e490775f9154d71638bfdc72e640a6","modified":1662110698344},{"_id":"themes/auto/source/css/_partial/sidebar-aside.styl","hash":"70e9336ec3a49ef98d257fce7a395136790df7ee","modified":1662110698347},{"_id":"themes/auto/source/css/_partial/highlight.styl","hash":"ac19f1621305ca9f6a7b74acd211a4c0d88690bd","modified":1662110698345},{"_id":"themes/auto/source/css/_partial/mobile.styl","hash":"b1830271b48c9353856d5760e2ea736a5cc2896c","modified":1662110698346},{"_id":"themes/auto/source/css/_partial/others.styl","hash":"05447034ecbbc9d2416d0cf735f34e7f801e04d4","modified":1662110698346},{"_id":"themes/auto/source/css/_partial/sidebar-bottom.styl","hash":"d8725966507e8c7e3f42b9e0a14761818f237118","modified":1662110698347},{"_id":"themes/auto/source/css/_partial/sidebar.styl","hash":"156197ec3f9ca2ca4df67a8f409ea5c28294752f","modified":1662110698348},{"_id":"themes/auto/source/css/_partial/archive.styl","hash":"9e574d8eb1a5285ec3b4346607414770d2f7e0ff","modified":1662110698342},{"_id":"themes/auto/source/css/_util/grid.styl","hash":"1aa883ab432d9e4139c89dcbd40ae2bd1528d029","modified":1662110698349},{"_id":"themes/auto/source/css/_util/mixin.styl","hash":"429bad87fc156eacf226c5e35b0eafc277f2504b","modified":1662110698349},{"_id":"themes/auto/source/js/jquery-3.4.1.min.js","hash":"b15f7cfa79519756dff1ad22553fd0ed09024343","modified":1662110698378},{"_id":"themes/auto/source/fancybox/jquery.fancybox.min.js","hash":"eef46b6fb2e460838cd7328a6e13ecda0cb1e194","modified":1662110698376},{"_id":"themes/auto/source/css/fonts/fontawesome-webfont.woff","hash":"28b782240b3e76db824e12c02754a9731a167527","modified":1662110698360},{"_id":"themes/auto/source/css/fonts/fontawesome-webfont.woff2","hash":"d6f48cba7d076fb6f2fd6ba993a75b9dc1ecbf0c","modified":1662110698361},{"_id":"themes/auto/source/css/fonts/fontawesome-webfont.eot","hash":"d980c2ce873dc43af460d4d572d441304499f400","modified":1662110698353},{"_id":"themes/auto/source/css/fonts/fontawesome-webfont.ttf","hash":"13b1eab65a983c7a73bc7997c479d66943f7c6cb","modified":1662110698359},{"_id":"themes/auto/source/css/fonts/FontAwesome.otf","hash":"048707bc52ac4b6563aaa383bfe8660a0ddc908c","modified":1662110698352},{"_id":"themes/auto/source/css/images/banner.jpg","hash":"cf3244c84ad947031e3f0a28634dc0f32779775c","modified":1662630473568},{"_id":"themes/auto/Auto.png","hash":"7c4349ec32dd5b2097699424f89bb5dd0d809935","modified":1662110698307},{"_id":"themes/auto/screenshots/hexo-theme-auto.png","hash":"e75996a3e7e530319faf9c00b912273fcedbe938","modified":1662110698340},{"_id":"themes/auto/source/css/fonts/fontawesome-webfont.svg","hash":"b5483b11f8ba213e733b5b8af9927a04fec996f6","modified":1662110698356},{"_id":"public/tags/index.html","hash":"b9e40f98eb9ebb4d75970c011f89f3f8db39d9f0","modified":1663765241035},{"_id":"public/categories/index.html","hash":"2dbbcd6346542606c3d580d9b6d7c602a88a7fe4","modified":1663765241035},{"_id":"public/archives/index.html","hash":"4456267d981460a3de8619f12fe74f1b17f24e59","modified":1663765241035},{"_id":"public/2022/What-kind-of-diseases-or-conditions-can-be-diagnosed-through-in-vitro-tests/index.html","hash":"640cecc91d9cb0953c5878a2cee689eeeee67cde","modified":1663765241035},{"_id":"public/archives/2022/index.html","hash":"2efb37fdb7367ffb3c55c5307038a3df95fb8c97","modified":1663765241035},{"_id":"public/archives/2022/09/index.html","hash":"f644f1356dba86e59012de387666ce41ef4bb647","modified":1663765241035},{"_id":"public/categories/Vitro-Diagnostics/index.html","hash":"9eb6f48887f3cb1fda0e698d86b36c396bef0015","modified":1663765241035},{"_id":"public/index.html","hash":"f26189e338fc1a26076394c53adab6ddd35e83e1","modified":1663765241035},{"_id":"public/js/script.js","hash":"fa1dd22cfc17353abef4a09e7dc9816e5eda7d5b","modified":1662695252728},{"_id":"public/fancybox/jquery.fancybox.min.css","hash":"1be9b79be02a1cfc5d96c4a5e0feb8f472babd95","modified":1662695252728},{"_id":"public/css/style.css","hash":"82be85f5b52c45ba0045eda0cd0dedba82512ac1","modified":1662695252728},{"_id":"public/js/jquery-3.4.1.min.js","hash":"88523924351bac0b5d560fe0c5781e2556e7693d","modified":1662695252728},{"_id":"public/fancybox/jquery.fancybox.min.js","hash":"6181412e73966696d08e1e5b1243a572d0f22ba6","modified":1662695252728},{"_id":"public/css/fonts/fontawesome-webfont.woff","hash":"28b782240b3e76db824e12c02754a9731a167527","modified":1662695252728},{"_id":"public/css/fonts/fontawesome-webfont.woff2","hash":"d6f48cba7d076fb6f2fd6ba993a75b9dc1ecbf0c","modified":1662695252728},{"_id":"public/css/fonts/FontAwesome.otf","hash":"048707bc52ac4b6563aaa383bfe8660a0ddc908c","modified":1662695252728},{"_id":"public/css/fonts/fontawesome-webfont.eot","hash":"d980c2ce873dc43af460d4d572d441304499f400","modified":1662695252728},{"_id":"public/css/fonts/fontawesome-webfont.ttf","hash":"13b1eab65a983c7a73bc7997c479d66943f7c6cb","modified":1662695252728},{"_id":"public/css/images/banner.jpg","hash":"cf3244c84ad947031e3f0a28634dc0f32779775c","modified":1662695252728},{"_id":"public/css/fonts/fontawesome-webfont.svg","hash":"b5483b11f8ba213e733b5b8af9927a04fec996f6","modified":1662695252728},{"_id":"source/_posts/What-is-the-clinical-performance-of-a-new-in-vitro-diagnostic-medical-device.md","hash":"923cf7c3bbe6f7e7e903ed167f8811e520610d18","modified":1663765239577},{"_id":"public/2022/What-is-the-clinical-performance-of-a-new-in-vitro-diagnostic-medical-device/index.html","hash":"500d1c7a9f0453cff4c94d5a18cb17c270c62ad5","modified":1663765241035}],"Category":[{"name":"Vitro Diagnostics","_id":"cl7txto570003x0v56nad52qa"}],"Data":[],"Page":[{"title":"tags","date":"2022-09-09T03:47:19.000Z","type":"tags","layout":"tags","_content":"","source":"tags/index.md","raw":"---\ntitle: tags\ndate: 2022-09-09 11:47:19\ntype: \"tags\"\nlayout: \"tags\"\n---\n","updated":"2022-09-09T03:47:19.335Z","path":"tags/index.html","comments":1,"_id":"cl7txto4u0000x0v584ct0syx","content":"","site":{"data":{}},"excerpt":"","more":""},{"title":"categories","date":"2022-09-09T03:47:18.000Z","type":"categories","layout":"categories","_content":"","source":"categories/index.md","raw":"---\ntitle: categories\ndate: 2022-09-09 11:47:18\ntype: \"categories\"\nlayout: \"categories\"\n---\n","updated":"2022-09-09T03:47:18.051Z","path":"categories/index.html","comments":1,"_id":"cl7txto4x0001x0v5gwc16jxq","content":"","site":{"data":{}},"excerpt":"","more":""}],"Post":[{"title":"What kind of diseases or conditions can be diagnosed through in vitro tests","date":"2022-09-09T03:47:31.000Z","_content":"\n\n#  What kind of diseases or conditions can be diagnosed through in vitro tests?\n\nIn vitro diagnostics, also called \"IVD\", are tests that are performed on tissue or fluid samples that have been removed from the body. These tests can be used to diagnose a variety of diseases or conditions.\n\nOne common use of IVD is to detect the presence of infectious agents, such as viruses or bacteria. Infectious agents can be detected through various methods, including PCR and immunoassays.\n\nIVD can also be used to detect genetic abnormalities. For example, many prenatal tests are performed using in vitro methods. These tests can be used to detect Down Syndrome, cystic fibrosis, and other genetic disorders.\n\nIVD can also be used to detect cancer. For example, certain types of cancer can be detected through the use of monoclonal antibodies.\n\nFinally, IVD can be used to monitor the progress of a treatment or to determine if a patient has responded to a treatment. This is commonly done with chemotherapy drugs; by measuring the levels of certain chemicals in the blood, doctors can determine whether a patient is responding to chemotherapy or not.\n\n#  How accurate are the results of in vitro tests?\n\nIn vitro tests are a valuable tool for understanding the effects of drugs and other chemicals on cells. However, the results of these tests can be misleading if not interpreted correctly.\n\nOne common source of error is the use of too few cells in the assay. When there are not enough cells, the drug or chemical may not be able to exert its full effect. As a result, the results of the assay may be inaccurate.\n\nAnother potential source of error is variability in cell culture conditions. Cells grown in different media, or under different environmental conditions, may respond differently to a drug or chemical. This can lead to inaccurate results.\n\nIt is important to remember that in vitro tests should be used as a tool to help guide further experimentation, rather than as gospel truth. The results of these tests should always be interpreted with caution, and verified through additional experiments.\n\n#  Are there any risks associated with getting in vitro diagnostic tests?\n\nThere are a few risks associated with in vitro diagnostic tests. One is the potential for contamination of the sample. Another is the possibility that the test results will be inaccurate. The technician performing the test must be careful to avoid contamination and to follow the test protocol accurately.\n\n#  How much do in vitro diagnostic tests cost?\n\nIVD or in vitro diagnostic testing is a type of medical test that is conducted in a laboratory setting. It involves the examination of cells, tissues, and body fluids to diagnose various medical conditions. The cost of IVD tests can vary depending on the type of test that is being performed.\n\nOne common type of IVD test is a pregnancy test. Pregnancy tests can range in price from about $5 to $25. Other common types of IVD tests include blood tests and urine tests. Blood tests can cost anywhere from $10 to $200, while urine tests can cost between $5 and $50.\n\nSome specialized IVD tests may be more expensive. For example, a genetic test to determine the risk of developing cancer could cost several thousand dollars. However, most IVD tests are relatively affordable and are typically covered by insurance plans.\n\nOverall, IVD testing is an important tool that can help physicians diagnose a variety of medical conditions. The cost of these tests varies depending on the specific test being performed, but they are generally relatively affordable.\n\n#  What kind of information will I receive after getting an in vitro diagnostic test?\n\nWhen you get an in vitro diagnostic test, the healthcare provider will give you a report of your results. This report will include information about your test results and what they mean. The report will also list recommendations for follow-up care, if necessary.","source":"_posts/What-kind-of-diseases-or-conditions-can-be-diagnosed-through-in-vitro-tests.md","raw":"---\ntitle: What kind of diseases or conditions can be diagnosed through in vitro tests\ndate: 2022-09-09 11:47:31\ncategories:\n- Vitro Diagnostics\ntags:\n---\n\n\n#  What kind of diseases or conditions can be diagnosed through in vitro tests?\n\nIn vitro diagnostics, also called \"IVD\", are tests that are performed on tissue or fluid samples that have been removed from the body. These tests can be used to diagnose a variety of diseases or conditions.\n\nOne common use of IVD is to detect the presence of infectious agents, such as viruses or bacteria. Infectious agents can be detected through various methods, including PCR and immunoassays.\n\nIVD can also be used to detect genetic abnormalities. For example, many prenatal tests are performed using in vitro methods. These tests can be used to detect Down Syndrome, cystic fibrosis, and other genetic disorders.\n\nIVD can also be used to detect cancer. For example, certain types of cancer can be detected through the use of monoclonal antibodies.\n\nFinally, IVD can be used to monitor the progress of a treatment or to determine if a patient has responded to a treatment. This is commonly done with chemotherapy drugs; by measuring the levels of certain chemicals in the blood, doctors can determine whether a patient is responding to chemotherapy or not.\n\n#  How accurate are the results of in vitro tests?\n\nIn vitro tests are a valuable tool for understanding the effects of drugs and other chemicals on cells. However, the results of these tests can be misleading if not interpreted correctly.\n\nOne common source of error is the use of too few cells in the assay. When there are not enough cells, the drug or chemical may not be able to exert its full effect. As a result, the results of the assay may be inaccurate.\n\nAnother potential source of error is variability in cell culture conditions. Cells grown in different media, or under different environmental conditions, may respond differently to a drug or chemical. This can lead to inaccurate results.\n\nIt is important to remember that in vitro tests should be used as a tool to help guide further experimentation, rather than as gospel truth. The results of these tests should always be interpreted with caution, and verified through additional experiments.\n\n#  Are there any risks associated with getting in vitro diagnostic tests?\n\nThere are a few risks associated with in vitro diagnostic tests. One is the potential for contamination of the sample. Another is the possibility that the test results will be inaccurate. The technician performing the test must be careful to avoid contamination and to follow the test protocol accurately.\n\n#  How much do in vitro diagnostic tests cost?\n\nIVD or in vitro diagnostic testing is a type of medical test that is conducted in a laboratory setting. It involves the examination of cells, tissues, and body fluids to diagnose various medical conditions. The cost of IVD tests can vary depending on the type of test that is being performed.\n\nOne common type of IVD test is a pregnancy test. Pregnancy tests can range in price from about $5 to $25. Other common types of IVD tests include blood tests and urine tests. Blood tests can cost anywhere from $10 to $200, while urine tests can cost between $5 and $50.\n\nSome specialized IVD tests may be more expensive. For example, a genetic test to determine the risk of developing cancer could cost several thousand dollars. However, most IVD tests are relatively affordable and are typically covered by insurance plans.\n\nOverall, IVD testing is an important tool that can help physicians diagnose a variety of medical conditions. The cost of these tests varies depending on the specific test being performed, but they are generally relatively affordable.\n\n#  What kind of information will I receive after getting an in vitro diagnostic test?\n\nWhen you get an in vitro diagnostic test, the healthcare provider will give you a report of your results. This report will include information about your test results and what they mean. The report will also list recommendations for follow-up care, if necessary.","slug":"What-kind-of-diseases-or-conditions-can-be-diagnosed-through-in-vitro-tests","published":1,"updated":"2022-09-09T03:47:31.791Z","comments":1,"layout":"post","photos":[],"link":"","_id":"cl7txto530002x0v53xslgxyq","content":"<h1 id=\"What-kind-of-diseases-or-conditions-can-be-diagnosed-through-in-vitro-tests\"><a href=\"#What-kind-of-diseases-or-conditions-can-be-diagnosed-through-in-vitro-tests\" class=\"headerlink\" title=\"What kind of diseases or conditions can be diagnosed through in vitro tests?\"></a>What kind of diseases or conditions can be diagnosed through in vitro tests?</h1><p>In vitro diagnostics, also called “IVD”, are tests that are performed on tissue or fluid samples that have been removed from the body. These tests can be used to diagnose a variety of diseases or conditions.</p>\n<p>One common use of IVD is to detect the presence of infectious agents, such as viruses or bacteria. Infectious agents can be detected through various methods, including PCR and immunoassays.</p>\n<p>IVD can also be used to detect genetic abnormalities. For example, many prenatal tests are performed using in vitro methods. These tests can be used to detect Down Syndrome, cystic fibrosis, and other genetic disorders.</p>\n<p>IVD can also be used to detect cancer. For example, certain types of cancer can be detected through the use of monoclonal antibodies.</p>\n<p>Finally, IVD can be used to monitor the progress of a treatment or to determine if a patient has responded to a treatment. This is commonly done with chemotherapy drugs; by measuring the levels of certain chemicals in the blood, doctors can determine whether a patient is responding to chemotherapy or not.</p>\n<h1 id=\"How-accurate-are-the-results-of-in-vitro-tests\"><a href=\"#How-accurate-are-the-results-of-in-vitro-tests\" class=\"headerlink\" title=\"How accurate are the results of in vitro tests?\"></a>How accurate are the results of in vitro tests?</h1><p>In vitro tests are a valuable tool for understanding the effects of drugs and other chemicals on cells. However, the results of these tests can be misleading if not interpreted correctly.</p>\n<p>One common source of error is the use of too few cells in the assay. When there are not enough cells, the drug or chemical may not be able to exert its full effect. As a result, the results of the assay may be inaccurate.</p>\n<p>Another potential source of error is variability in cell culture conditions. Cells grown in different media, or under different environmental conditions, may respond differently to a drug or chemical. This can lead to inaccurate results.</p>\n<p>It is important to remember that in vitro tests should be used as a tool to help guide further experimentation, rather than as gospel truth. The results of these tests should always be interpreted with caution, and verified through additional experiments.</p>\n<h1 id=\"Are-there-any-risks-associated-with-getting-in-vitro-diagnostic-tests\"><a href=\"#Are-there-any-risks-associated-with-getting-in-vitro-diagnostic-tests\" class=\"headerlink\" title=\"Are there any risks associated with getting in vitro diagnostic tests?\"></a>Are there any risks associated with getting in vitro diagnostic tests?</h1><p>There are a few risks associated with in vitro diagnostic tests. One is the potential for contamination of the sample. Another is the possibility that the test results will be inaccurate. The technician performing the test must be careful to avoid contamination and to follow the test protocol accurately.</p>\n<h1 id=\"How-much-do-in-vitro-diagnostic-tests-cost\"><a href=\"#How-much-do-in-vitro-diagnostic-tests-cost\" class=\"headerlink\" title=\"How much do in vitro diagnostic tests cost?\"></a>How much do in vitro diagnostic tests cost?</h1><p>IVD or in vitro diagnostic testing is a type of medical test that is conducted in a laboratory setting. It involves the examination of cells, tissues, and body fluids to diagnose various medical conditions. The cost of IVD tests can vary depending on the type of test that is being performed.</p>\n<p>One common type of IVD test is a pregnancy test. Pregnancy tests can range in price from about $5 to $25. Other common types of IVD tests include blood tests and urine tests. Blood tests can cost anywhere from $10 to $200, while urine tests can cost between $5 and $50.</p>\n<p>Some specialized IVD tests may be more expensive. For example, a genetic test to determine the risk of developing cancer could cost several thousand dollars. However, most IVD tests are relatively affordable and are typically covered by insurance plans.</p>\n<p>Overall, IVD testing is an important tool that can help physicians diagnose a variety of medical conditions. The cost of these tests varies depending on the specific test being performed, but they are generally relatively affordable.</p>\n<h1 id=\"What-kind-of-information-will-I-receive-after-getting-an-in-vitro-diagnostic-test\"><a href=\"#What-kind-of-information-will-I-receive-after-getting-an-in-vitro-diagnostic-test\" class=\"headerlink\" title=\"What kind of information will I receive after getting an in vitro diagnostic test?\"></a>What kind of information will I receive after getting an in vitro diagnostic test?</h1><p>When you get an in vitro diagnostic test, the healthcare provider will give you a report of your results. This report will include information about your test results and what they mean. The report will also list recommendations for follow-up care, if necessary.</p>\n","site":{"data":{}},"excerpt":"","more":"<h1 id=\"What-kind-of-diseases-or-conditions-can-be-diagnosed-through-in-vitro-tests\"><a href=\"#What-kind-of-diseases-or-conditions-can-be-diagnosed-through-in-vitro-tests\" class=\"headerlink\" title=\"What kind of diseases or conditions can be diagnosed through in vitro tests?\"></a>What kind of diseases or conditions can be diagnosed through in vitro tests?</h1><p>In vitro diagnostics, also called “IVD”, are tests that are performed on tissue or fluid samples that have been removed from the body. These tests can be used to diagnose a variety of diseases or conditions.</p>\n<p>One common use of IVD is to detect the presence of infectious agents, such as viruses or bacteria. Infectious agents can be detected through various methods, including PCR and immunoassays.</p>\n<p>IVD can also be used to detect genetic abnormalities. For example, many prenatal tests are performed using in vitro methods. These tests can be used to detect Down Syndrome, cystic fibrosis, and other genetic disorders.</p>\n<p>IVD can also be used to detect cancer. For example, certain types of cancer can be detected through the use of monoclonal antibodies.</p>\n<p>Finally, IVD can be used to monitor the progress of a treatment or to determine if a patient has responded to a treatment. This is commonly done with chemotherapy drugs; by measuring the levels of certain chemicals in the blood, doctors can determine whether a patient is responding to chemotherapy or not.</p>\n<h1 id=\"How-accurate-are-the-results-of-in-vitro-tests\"><a href=\"#How-accurate-are-the-results-of-in-vitro-tests\" class=\"headerlink\" title=\"How accurate are the results of in vitro tests?\"></a>How accurate are the results of in vitro tests?</h1><p>In vitro tests are a valuable tool for understanding the effects of drugs and other chemicals on cells. However, the results of these tests can be misleading if not interpreted correctly.</p>\n<p>One common source of error is the use of too few cells in the assay. When there are not enough cells, the drug or chemical may not be able to exert its full effect. As a result, the results of the assay may be inaccurate.</p>\n<p>Another potential source of error is variability in cell culture conditions. Cells grown in different media, or under different environmental conditions, may respond differently to a drug or chemical. This can lead to inaccurate results.</p>\n<p>It is important to remember that in vitro tests should be used as a tool to help guide further experimentation, rather than as gospel truth. The results of these tests should always be interpreted with caution, and verified through additional experiments.</p>\n<h1 id=\"Are-there-any-risks-associated-with-getting-in-vitro-diagnostic-tests\"><a href=\"#Are-there-any-risks-associated-with-getting-in-vitro-diagnostic-tests\" class=\"headerlink\" title=\"Are there any risks associated with getting in vitro diagnostic tests?\"></a>Are there any risks associated with getting in vitro diagnostic tests?</h1><p>There are a few risks associated with in vitro diagnostic tests. One is the potential for contamination of the sample. Another is the possibility that the test results will be inaccurate. The technician performing the test must be careful to avoid contamination and to follow the test protocol accurately.</p>\n<h1 id=\"How-much-do-in-vitro-diagnostic-tests-cost\"><a href=\"#How-much-do-in-vitro-diagnostic-tests-cost\" class=\"headerlink\" title=\"How much do in vitro diagnostic tests cost?\"></a>How much do in vitro diagnostic tests cost?</h1><p>IVD or in vitro diagnostic testing is a type of medical test that is conducted in a laboratory setting. It involves the examination of cells, tissues, and body fluids to diagnose various medical conditions. The cost of IVD tests can vary depending on the type of test that is being performed.</p>\n<p>One common type of IVD test is a pregnancy test. Pregnancy tests can range in price from about $5 to $25. Other common types of IVD tests include blood tests and urine tests. Blood tests can cost anywhere from $10 to $200, while urine tests can cost between $5 and $50.</p>\n<p>Some specialized IVD tests may be more expensive. For example, a genetic test to determine the risk of developing cancer could cost several thousand dollars. However, most IVD tests are relatively affordable and are typically covered by insurance plans.</p>\n<p>Overall, IVD testing is an important tool that can help physicians diagnose a variety of medical conditions. The cost of these tests varies depending on the specific test being performed, but they are generally relatively affordable.</p>\n<h1 id=\"What-kind-of-information-will-I-receive-after-getting-an-in-vitro-diagnostic-test\"><a href=\"#What-kind-of-information-will-I-receive-after-getting-an-in-vitro-diagnostic-test\" class=\"headerlink\" title=\"What kind of information will I receive after getting an in vitro diagnostic test?\"></a>What kind of information will I receive after getting an in vitro diagnostic test?</h1><p>When you get an in vitro diagnostic test, the healthcare provider will give you a report of your results. This report will include information about your test results and what they mean. The report will also list recommendations for follow-up care, if necessary.</p>\n"},{"title":"What is the clinical performance of a new in vitro diagnostic medical device","date":"2022-09-21T13:00:39.000Z","_content":"\n\n#  What is the clinical performance of a new in vitro diagnostic medical device?\n\nThe clinical performance of a new in vitro diagnostic medical device is how well it works when used by healthcare professionals to diagnose a patient’s illness. This can be determined through clinical trials, which are studies that compare the results of using the new device with those of using current methods.\n\nIf the new device performs as well as or better than the current methods, then it is likely to be adopted by healthcare professionals. However, if the new device does not perform as well, then it may not gain widespread acceptance.\n\nIt is important for companies that develop new in vitro diagnostic devices to conduct rigorous clinical trials in order to ensure that their products are safe and effective. By doing so, they can improve the chances of their devices being adopted by healthcare professionals and help improve patient outcomes.\n\n#  How will market authorization be granted for a new in vitro diagnostic medical device?\n\nA new in vitro diagnostic medical device faces a rigorous and expensive approval process before it can be marketed. The market authorization pathway for a new IVDMD is described below.\n\n1. The first step in the process is to file an application with the FDA's Center for Devices and Radiological Health (CDRH). The application must include a proposed product labeling, a description of the device, information on the manufacturing process, and test data demonstrating that the device meets FDA safety and efficacy standards.\n\n2. CDRH will review the application to make sure it is complete and that the proposed product labeling is acceptable. If additional information is needed, CDRH will contact the applicant.\n\n3. Once CDRH has everything it needs, it will begin its review of the data. This review can take many months or even years to complete.\n\n4. If CDRH finds that the device meets its safety and efficacy standards, it will issue a marketing authorization known as a premarket notification (PMN). A PMN authorizes commercial distribution of the device in the U.S.\n\n5. The applicant must then comply with all postmarket requirements outlined in the PMN, including submission of annual reports and reporting any adverse events associated with use of the device.\n\n#  What are the post-market surveillance requirements for a new in vitro diagnostic medical device?\n\nThe FDA has several post-market surveillance requirements for a new in vitro diagnostic (IVD) medical device. \n\nOne of the most important post-market surveillance requirements is the establishment and maintenance of a system to receive reports of device failures. This system must be able to track each individual device throughout its distribution and use. In addition, manufacturers must establish and maintain procedures for investigating and resolving complaints associated with their devices.\n\nThe FDA also requires that IVD manufacturers participate in a program called MedWatch. This program is responsible for collecting information about adverse events related to medical devices, including IVDs. The data collected through this program helps the FDA identify potential risks associated with medical devices, including IVDs.\n\nManufacturers must also submit Periodic Safety Update Reports (PSURs). PSURs are required every 6 months for the first 3 years after a device is placed on the market, then annually thereafter. PSURs provide updates on the safety and effectiveness of a device, as well as any new information that may impact the safety or effectiveness of the device.\n\n#  When can manufacturers begin selling new in vitro diagnostic medical devices?\n\nThe sale of new in vitro diagnostic medical devices (IVDs) may commence as soon as the product is cleared by the Food and Drug Administration (FDA). The FDA's Center for Devices and Radiological Health (CDRH) is responsible for regulating all medical devices, including IVDs. In order to market a new IVD, manufacturers must file a 510(k) application with the FDA.\n\nA510(k) is a premarket notification submission that allows the FDA to determine whether a new device is substantially equivalent to an already legally marketed device. The 510(k) submission must include information on the device's intended use, design, manufacturing, labeling and performance. The FDA will also review safety and effectiveness data for the new device.\n\nIf a new IVD is found to be substantially equivalent to an already marketed device, then it can be sold in the United States. If a new IVD is not substantially equivalent to an already marketed device, then it may require additional clinical testing or regulatory review before it can be sold in the United States.\n\n#  What are the consequences for not complying with New In Vitro Diagnostic Medical Devices Regulation?\n\nSince the New In Vitro Diagnostic Medical Devices Regulation (IVDR) was implemented in May 2017, companies have been struggling to comply with its requirements. Failing to do so can have serious consequences, including being unable to market devices in the European Union (EU) and being fined.\n\nThe IVDR lays out specific regulations for medical devices that are intended to test substances in the human body, such as blood or tissue. These types of devices are known as in vitro diagnostics (IVDs).\n\nUnder the IVDR, all manufacturers and distributors of IVDs must apply for a unique device identifier (UDI) and register their devices with a European online portal. They must also provide detailed product information, including a description of the device, how it works, how it’s used, and what risks it poses.\n\nDevices that don’t meet the requirements of the IVDR can be seized by EU authorities. Companies that continue to sell non-compliant devices can be fined up to 4% of their annual global turnover or €20 million (whichever is greater), whichever is greater.\n\nThus far, regulators have been lenient in enforcing these regulations. However, that may change in the coming months as authorities become better acquainted with the new rules. Companies that haven’t yet complied with the IVDR should do so as soon as possible to avoid any penalties.","source":"_posts/What-is-the-clinical-performance-of-a-new-in-vitro-diagnostic-medical-device.md","raw":"---\ntitle: What is the clinical performance of a new in vitro diagnostic medical device\ndate: 2022-09-21 21:00:39\ncategories:\n- Vitro Diagnostics\ntags:\n---\n\n\n#  What is the clinical performance of a new in vitro diagnostic medical device?\n\nThe clinical performance of a new in vitro diagnostic medical device is how well it works when used by healthcare professionals to diagnose a patient’s illness. This can be determined through clinical trials, which are studies that compare the results of using the new device with those of using current methods.\n\nIf the new device performs as well as or better than the current methods, then it is likely to be adopted by healthcare professionals. However, if the new device does not perform as well, then it may not gain widespread acceptance.\n\nIt is important for companies that develop new in vitro diagnostic devices to conduct rigorous clinical trials in order to ensure that their products are safe and effective. By doing so, they can improve the chances of their devices being adopted by healthcare professionals and help improve patient outcomes.\n\n#  How will market authorization be granted for a new in vitro diagnostic medical device?\n\nA new in vitro diagnostic medical device faces a rigorous and expensive approval process before it can be marketed. The market authorization pathway for a new IVDMD is described below.\n\n1. The first step in the process is to file an application with the FDA's Center for Devices and Radiological Health (CDRH). The application must include a proposed product labeling, a description of the device, information on the manufacturing process, and test data demonstrating that the device meets FDA safety and efficacy standards.\n\n2. CDRH will review the application to make sure it is complete and that the proposed product labeling is acceptable. If additional information is needed, CDRH will contact the applicant.\n\n3. Once CDRH has everything it needs, it will begin its review of the data. This review can take many months or even years to complete.\n\n4. If CDRH finds that the device meets its safety and efficacy standards, it will issue a marketing authorization known as a premarket notification (PMN). A PMN authorizes commercial distribution of the device in the U.S.\n\n5. The applicant must then comply with all postmarket requirements outlined in the PMN, including submission of annual reports and reporting any adverse events associated with use of the device.\n\n#  What are the post-market surveillance requirements for a new in vitro diagnostic medical device?\n\nThe FDA has several post-market surveillance requirements for a new in vitro diagnostic (IVD) medical device. \n\nOne of the most important post-market surveillance requirements is the establishment and maintenance of a system to receive reports of device failures. This system must be able to track each individual device throughout its distribution and use. In addition, manufacturers must establish and maintain procedures for investigating and resolving complaints associated with their devices.\n\nThe FDA also requires that IVD manufacturers participate in a program called MedWatch. This program is responsible for collecting information about adverse events related to medical devices, including IVDs. The data collected through this program helps the FDA identify potential risks associated with medical devices, including IVDs.\n\nManufacturers must also submit Periodic Safety Update Reports (PSURs). PSURs are required every 6 months for the first 3 years after a device is placed on the market, then annually thereafter. PSURs provide updates on the safety and effectiveness of a device, as well as any new information that may impact the safety or effectiveness of the device.\n\n#  When can manufacturers begin selling new in vitro diagnostic medical devices?\n\nThe sale of new in vitro diagnostic medical devices (IVDs) may commence as soon as the product is cleared by the Food and Drug Administration (FDA). The FDA's Center for Devices and Radiological Health (CDRH) is responsible for regulating all medical devices, including IVDs. In order to market a new IVD, manufacturers must file a 510(k) application with the FDA.\n\nA510(k) is a premarket notification submission that allows the FDA to determine whether a new device is substantially equivalent to an already legally marketed device. The 510(k) submission must include information on the device's intended use, design, manufacturing, labeling and performance. The FDA will also review safety and effectiveness data for the new device.\n\nIf a new IVD is found to be substantially equivalent to an already marketed device, then it can be sold in the United States. If a new IVD is not substantially equivalent to an already marketed device, then it may require additional clinical testing or regulatory review before it can be sold in the United States.\n\n#  What are the consequences for not complying with New In Vitro Diagnostic Medical Devices Regulation?\n\nSince the New In Vitro Diagnostic Medical Devices Regulation (IVDR) was implemented in May 2017, companies have been struggling to comply with its requirements. Failing to do so can have serious consequences, including being unable to market devices in the European Union (EU) and being fined.\n\nThe IVDR lays out specific regulations for medical devices that are intended to test substances in the human body, such as blood or tissue. These types of devices are known as in vitro diagnostics (IVDs).\n\nUnder the IVDR, all manufacturers and distributors of IVDs must apply for a unique device identifier (UDI) and register their devices with a European online portal. They must also provide detailed product information, including a description of the device, how it works, how it’s used, and what risks it poses.\n\nDevices that don’t meet the requirements of the IVDR can be seized by EU authorities. Companies that continue to sell non-compliant devices can be fined up to 4% of their annual global turnover or €20 million (whichever is greater), whichever is greater.\n\nThus far, regulators have been lenient in enforcing these regulations. However, that may change in the coming months as authorities become better acquainted with the new rules. Companies that haven’t yet complied with the IVDR should do so as soon as possible to avoid any penalties.","slug":"What-is-the-clinical-performance-of-a-new-in-vitro-diagnostic-medical-device","published":1,"updated":"2022-09-21T13:00:39.577Z","comments":1,"layout":"post","photos":[],"link":"","_id":"cl8bmv8n30000hkv52v3cdbbv","content":"<h1 id=\"What-is-the-clinical-performance-of-a-new-in-vitro-diagnostic-medical-device\"><a href=\"#What-is-the-clinical-performance-of-a-new-in-vitro-diagnostic-medical-device\" class=\"headerlink\" title=\"What is the clinical performance of a new in vitro diagnostic medical device?\"></a>What is the clinical performance of a new in vitro diagnostic medical device?</h1><p>The clinical performance of a new in vitro diagnostic medical device is how well it works when used by healthcare professionals to diagnose a patient’s illness. This can be determined through clinical trials, which are studies that compare the results of using the new device with those of using current methods.</p>\n<p>If the new device performs as well as or better than the current methods, then it is likely to be adopted by healthcare professionals. However, if the new device does not perform as well, then it may not gain widespread acceptance.</p>\n<p>It is important for companies that develop new in vitro diagnostic devices to conduct rigorous clinical trials in order to ensure that their products are safe and effective. By doing so, they can improve the chances of their devices being adopted by healthcare professionals and help improve patient outcomes.</p>\n<h1 id=\"How-will-market-authorization-be-granted-for-a-new-in-vitro-diagnostic-medical-device\"><a href=\"#How-will-market-authorization-be-granted-for-a-new-in-vitro-diagnostic-medical-device\" class=\"headerlink\" title=\"How will market authorization be granted for a new in vitro diagnostic medical device?\"></a>How will market authorization be granted for a new in vitro diagnostic medical device?</h1><p>A new in vitro diagnostic medical device faces a rigorous and expensive approval process before it can be marketed. The market authorization pathway for a new IVDMD is described below.</p>\n<ol>\n<li><p>The first step in the process is to file an application with the FDA’s Center for Devices and Radiological Health (CDRH). The application must include a proposed product labeling, a description of the device, information on the manufacturing process, and test data demonstrating that the device meets FDA safety and efficacy standards.</p>\n</li>\n<li><p>CDRH will review the application to make sure it is complete and that the proposed product labeling is acceptable. If additional information is needed, CDRH will contact the applicant.</p>\n</li>\n<li><p>Once CDRH has everything it needs, it will begin its review of the data. This review can take many months or even years to complete.</p>\n</li>\n<li><p>If CDRH finds that the device meets its safety and efficacy standards, it will issue a marketing authorization known as a premarket notification (PMN). A PMN authorizes commercial distribution of the device in the U.S.</p>\n</li>\n<li><p>The applicant must then comply with all postmarket requirements outlined in the PMN, including submission of annual reports and reporting any adverse events associated with use of the device.</p>\n</li>\n</ol>\n<h1 id=\"What-are-the-post-market-surveillance-requirements-for-a-new-in-vitro-diagnostic-medical-device\"><a href=\"#What-are-the-post-market-surveillance-requirements-for-a-new-in-vitro-diagnostic-medical-device\" class=\"headerlink\" title=\"What are the post-market surveillance requirements for a new in vitro diagnostic medical device?\"></a>What are the post-market surveillance requirements for a new in vitro diagnostic medical device?</h1><p>The FDA has several post-market surveillance requirements for a new in vitro diagnostic (IVD) medical device. </p>\n<p>One of the most important post-market surveillance requirements is the establishment and maintenance of a system to receive reports of device failures. This system must be able to track each individual device throughout its distribution and use. In addition, manufacturers must establish and maintain procedures for investigating and resolving complaints associated with their devices.</p>\n<p>The FDA also requires that IVD manufacturers participate in a program called MedWatch. This program is responsible for collecting information about adverse events related to medical devices, including IVDs. The data collected through this program helps the FDA identify potential risks associated with medical devices, including IVDs.</p>\n<p>Manufacturers must also submit Periodic Safety Update Reports (PSURs). PSURs are required every 6 months for the first 3 years after a device is placed on the market, then annually thereafter. PSURs provide updates on the safety and effectiveness of a device, as well as any new information that may impact the safety or effectiveness of the device.</p>\n<h1 id=\"When-can-manufacturers-begin-selling-new-in-vitro-diagnostic-medical-devices\"><a href=\"#When-can-manufacturers-begin-selling-new-in-vitro-diagnostic-medical-devices\" class=\"headerlink\" title=\"When can manufacturers begin selling new in vitro diagnostic medical devices?\"></a>When can manufacturers begin selling new in vitro diagnostic medical devices?</h1><p>The sale of new in vitro diagnostic medical devices (IVDs) may commence as soon as the product is cleared by the Food and Drug Administration (FDA). The FDA’s Center for Devices and Radiological Health (CDRH) is responsible for regulating all medical devices, including IVDs. In order to market a new IVD, manufacturers must file a 510(k) application with the FDA.</p>\n<p>A510(k) is a premarket notification submission that allows the FDA to determine whether a new device is substantially equivalent to an already legally marketed device. The 510(k) submission must include information on the device’s intended use, design, manufacturing, labeling and performance. The FDA will also review safety and effectiveness data for the new device.</p>\n<p>If a new IVD is found to be substantially equivalent to an already marketed device, then it can be sold in the United States. If a new IVD is not substantially equivalent to an already marketed device, then it may require additional clinical testing or regulatory review before it can be sold in the United States.</p>\n<h1 id=\"What-are-the-consequences-for-not-complying-with-New-In-Vitro-Diagnostic-Medical-Devices-Regulation\"><a href=\"#What-are-the-consequences-for-not-complying-with-New-In-Vitro-Diagnostic-Medical-Devices-Regulation\" class=\"headerlink\" title=\"What are the consequences for not complying with New In Vitro Diagnostic Medical Devices Regulation?\"></a>What are the consequences for not complying with New In Vitro Diagnostic Medical Devices Regulation?</h1><p>Since the New In Vitro Diagnostic Medical Devices Regulation (IVDR) was implemented in May 2017, companies have been struggling to comply with its requirements. Failing to do so can have serious consequences, including being unable to market devices in the European Union (EU) and being fined.</p>\n<p>The IVDR lays out specific regulations for medical devices that are intended to test substances in the human body, such as blood or tissue. These types of devices are known as in vitro diagnostics (IVDs).</p>\n<p>Under the IVDR, all manufacturers and distributors of IVDs must apply for a unique device identifier (UDI) and register their devices with a European online portal. They must also provide detailed product information, including a description of the device, how it works, how it’s used, and what risks it poses.</p>\n<p>Devices that don’t meet the requirements of the IVDR can be seized by EU authorities. Companies that continue to sell non-compliant devices can be fined up to 4% of their annual global turnover or €20 million (whichever is greater), whichever is greater.</p>\n<p>Thus far, regulators have been lenient in enforcing these regulations. However, that may change in the coming months as authorities become better acquainted with the new rules. Companies that haven’t yet complied with the IVDR should do so as soon as possible to avoid any penalties.</p>\n","site":{"data":{}},"excerpt":"","more":"<h1 id=\"What-is-the-clinical-performance-of-a-new-in-vitro-diagnostic-medical-device\"><a href=\"#What-is-the-clinical-performance-of-a-new-in-vitro-diagnostic-medical-device\" class=\"headerlink\" title=\"What is the clinical performance of a new in vitro diagnostic medical device?\"></a>What is the clinical performance of a new in vitro diagnostic medical device?</h1><p>The clinical performance of a new in vitro diagnostic medical device is how well it works when used by healthcare professionals to diagnose a patient’s illness. This can be determined through clinical trials, which are studies that compare the results of using the new device with those of using current methods.</p>\n<p>If the new device performs as well as or better than the current methods, then it is likely to be adopted by healthcare professionals. However, if the new device does not perform as well, then it may not gain widespread acceptance.</p>\n<p>It is important for companies that develop new in vitro diagnostic devices to conduct rigorous clinical trials in order to ensure that their products are safe and effective. By doing so, they can improve the chances of their devices being adopted by healthcare professionals and help improve patient outcomes.</p>\n<h1 id=\"How-will-market-authorization-be-granted-for-a-new-in-vitro-diagnostic-medical-device\"><a href=\"#How-will-market-authorization-be-granted-for-a-new-in-vitro-diagnostic-medical-device\" class=\"headerlink\" title=\"How will market authorization be granted for a new in vitro diagnostic medical device?\"></a>How will market authorization be granted for a new in vitro diagnostic medical device?</h1><p>A new in vitro diagnostic medical device faces a rigorous and expensive approval process before it can be marketed. The market authorization pathway for a new IVDMD is described below.</p>\n<ol>\n<li><p>The first step in the process is to file an application with the FDA’s Center for Devices and Radiological Health (CDRH). The application must include a proposed product labeling, a description of the device, information on the manufacturing process, and test data demonstrating that the device meets FDA safety and efficacy standards.</p>\n</li>\n<li><p>CDRH will review the application to make sure it is complete and that the proposed product labeling is acceptable. If additional information is needed, CDRH will contact the applicant.</p>\n</li>\n<li><p>Once CDRH has everything it needs, it will begin its review of the data. This review can take many months or even years to complete.</p>\n</li>\n<li><p>If CDRH finds that the device meets its safety and efficacy standards, it will issue a marketing authorization known as a premarket notification (PMN). A PMN authorizes commercial distribution of the device in the U.S.</p>\n</li>\n<li><p>The applicant must then comply with all postmarket requirements outlined in the PMN, including submission of annual reports and reporting any adverse events associated with use of the device.</p>\n</li>\n</ol>\n<h1 id=\"What-are-the-post-market-surveillance-requirements-for-a-new-in-vitro-diagnostic-medical-device\"><a href=\"#What-are-the-post-market-surveillance-requirements-for-a-new-in-vitro-diagnostic-medical-device\" class=\"headerlink\" title=\"What are the post-market surveillance requirements for a new in vitro diagnostic medical device?\"></a>What are the post-market surveillance requirements for a new in vitro diagnostic medical device?</h1><p>The FDA has several post-market surveillance requirements for a new in vitro diagnostic (IVD) medical device. </p>\n<p>One of the most important post-market surveillance requirements is the establishment and maintenance of a system to receive reports of device failures. This system must be able to track each individual device throughout its distribution and use. In addition, manufacturers must establish and maintain procedures for investigating and resolving complaints associated with their devices.</p>\n<p>The FDA also requires that IVD manufacturers participate in a program called MedWatch. This program is responsible for collecting information about adverse events related to medical devices, including IVDs. The data collected through this program helps the FDA identify potential risks associated with medical devices, including IVDs.</p>\n<p>Manufacturers must also submit Periodic Safety Update Reports (PSURs). PSURs are required every 6 months for the first 3 years after a device is placed on the market, then annually thereafter. PSURs provide updates on the safety and effectiveness of a device, as well as any new information that may impact the safety or effectiveness of the device.</p>\n<h1 id=\"When-can-manufacturers-begin-selling-new-in-vitro-diagnostic-medical-devices\"><a href=\"#When-can-manufacturers-begin-selling-new-in-vitro-diagnostic-medical-devices\" class=\"headerlink\" title=\"When can manufacturers begin selling new in vitro diagnostic medical devices?\"></a>When can manufacturers begin selling new in vitro diagnostic medical devices?</h1><p>The sale of new in vitro diagnostic medical devices (IVDs) may commence as soon as the product is cleared by the Food and Drug Administration (FDA). The FDA’s Center for Devices and Radiological Health (CDRH) is responsible for regulating all medical devices, including IVDs. In order to market a new IVD, manufacturers must file a 510(k) application with the FDA.</p>\n<p>A510(k) is a premarket notification submission that allows the FDA to determine whether a new device is substantially equivalent to an already legally marketed device. The 510(k) submission must include information on the device’s intended use, design, manufacturing, labeling and performance. The FDA will also review safety and effectiveness data for the new device.</p>\n<p>If a new IVD is found to be substantially equivalent to an already marketed device, then it can be sold in the United States. If a new IVD is not substantially equivalent to an already marketed device, then it may require additional clinical testing or regulatory review before it can be sold in the United States.</p>\n<h1 id=\"What-are-the-consequences-for-not-complying-with-New-In-Vitro-Diagnostic-Medical-Devices-Regulation\"><a href=\"#What-are-the-consequences-for-not-complying-with-New-In-Vitro-Diagnostic-Medical-Devices-Regulation\" class=\"headerlink\" title=\"What are the consequences for not complying with New In Vitro Diagnostic Medical Devices Regulation?\"></a>What are the consequences for not complying with New In Vitro Diagnostic Medical Devices Regulation?</h1><p>Since the New In Vitro Diagnostic Medical Devices Regulation (IVDR) was implemented in May 2017, companies have been struggling to comply with its requirements. Failing to do so can have serious consequences, including being unable to market devices in the European Union (EU) and being fined.</p>\n<p>The IVDR lays out specific regulations for medical devices that are intended to test substances in the human body, such as blood or tissue. These types of devices are known as in vitro diagnostics (IVDs).</p>\n<p>Under the IVDR, all manufacturers and distributors of IVDs must apply for a unique device identifier (UDI) and register their devices with a European online portal. They must also provide detailed product information, including a description of the device, how it works, how it’s used, and what risks it poses.</p>\n<p>Devices that don’t meet the requirements of the IVDR can be seized by EU authorities. Companies that continue to sell non-compliant devices can be fined up to 4% of their annual global turnover or €20 million (whichever is greater), whichever is greater.</p>\n<p>Thus far, regulators have been lenient in enforcing these regulations. However, that may change in the coming months as authorities become better acquainted with the new rules. Companies that haven’t yet complied with the IVDR should do so as soon as possible to avoid any penalties.</p>\n"}],"PostAsset":[],"PostCategory":[{"post_id":"cl7txto530002x0v53xslgxyq","category_id":"cl7txto570003x0v56nad52qa","_id":"cl7txto590004x0v5621p4x6q"},{"post_id":"cl8bmv8n30000hkv52v3cdbbv","category_id":"cl7txto570003x0v56nad52qa","_id":"cl8bmv8nb0001hkv54svgdvc8"}],"PostTag":[],"Tag":[]}}